Erythrocytes—the ‘house elves’ of photodynamic therapy

Photochemical and Photobiological Sciences

Volumn 3, Issue 11-12, 2004, Pages 981-989

  Kaestner, Lars ^a,b   Juzeniene, Asta ^a   Moan, Johan ^a  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; ANTIOXIDANT; BENZOPORPHYRIN DERIVATIVE; BILIRUBIN; DIPYRIDAMOLE; FERROCHELATASE; MEROCYANINE; METHYLENE BLUE; PHEOPHORBIDE; PHOTOFRIN II; PHOTOSENSITIZING AGENT; PHTHALOCYANINE ZINC; PROTOPORPHYRIN; TETRAPHENYLPORPHYRIN DERIVATIVE; UNCLASSIFIED DRUG; ZINC TETRABENZOPORPHINE;

APOPTOSIS; CELL DAMAGE; CELL POPULATION; CELL PROTECTION; CELL SURVIVAL; DRUG MECHANISM; DRUG STRUCTURE; ERYTHROCYTE; ERYTHROCYTE COUNT; ERYTHROPOIETIC PROTOPORPHYRIA; HEMOLYSIS; HUMAN; NONHUMAN; PHOTODEGRADATION; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PHOTOSENSITIZATION; PHOTOTOXICITY; PRIORITY JOURNAL; REVIEW; ULTRAVIOLET A RADIATION;

AVES;

EID: 13444268031     PISSN: 1474905X     EISSN: 14749092     Source Type: Journal    
DOI: 10.1039/b403127j     Document Type: Article

References (128)

1. M. Ochsner Photophysical and photobiological processes in the photodynamic therapy of tumours J. Photochem. Photobiol. B 1997 39 1-18.
2. J. Moan K. Berg The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen Photochem. Photobiol. 1991 53 549-553.
3. A. K. Cavalcante G. R. Martinez P. Di Mascio C. F. Menck L. F. Agnez-Lima Cytotoxicity and mutagenesis induced by singlet oxygen in wild type and DNA repair deficient Escherichia coli strains DNA Repair (Amsterdam) 2002 1 1051-1056.
4. M. C. DeRosa R. J. Crutchley Photosensitized singlet oxygen and its applications Coord. Chem. Rev. 2002 233–234 351-371.
5. H. von Tappeiner Ueber die Wirkung fluorescirender Stoffe auf Infusorien nach Versuchen von O. Raab Münch. Med. Wochenschr. 1900 47 5-7.
6. O. Raab Ueber die Wirkung fluorescirender Stoffe auf Infusorien Z. Biol. 1900 39 524-546.
7. H. von Tappeiner A. Jesionek Therapeutische Versuche mit fluoreszierenden Stoffen Münch. Med. Wochenschr. 1903 50 2042-2044.
8. L. Milgrom S. MacRobert Light years ahead Chem. Br. 1998 34 45-50.
9. F. Meyer-Betz Untersuchungen über die biologische (photodynamische) Wirkung des Hämatoporphyrins und anderer Derivate des Blut- und Gallenfarbstoffs Dtsch. Arch. Klin. Med. 1913 122 476-503.
10. W. Kosenow A. Treibs Lichtüberempfindlichkeit und Porphyrinämie Z. Kinderheilkd. 1953 73 82-92.
11. W. Kosenow Erythrozyten-Primärfluoreszenz bei Porphyrin-Dermatosen Med. Klin. 1954 49 1099-1103.
12. I. A. Magnus A. Jarrett T. A. Prankerd C. Rimington Erythropoietic protoporphyria. A new porphyria syndrome with solar urticaria due to protoporphyrinaemia Lancet 1961 2 448-451.
13. A. M. H. Gray Haematoporphyria congenital with hydroa vacciniforme and hirsuties Q. J. Med. 1926 19 381-392.
14. C. H. Gray A. Kulczycka D. C. Nicholson I. A. Magnus C. Rimington Isotope Studies on a Case of Erythropoietic Protoporphyria Clin. Sci. 1964 26 7-15.
15. B. Röder, Einführung in die molekulare Photobiophysik, ed. A. Schlachetzki and M. Schulz, Teubner, Stuttgart–Leipzig, 1999.
16. Q. Peng J. Moan M. Kongshaug J. F. Evensen H. Anholt C. Rimington Sensitizer for photodynamic therapy of cancer: a comparison of the tissue distribution of Photofrin II and aluminum phthalocyanine tetrasulfonate in nude mice bearing a human malignant tumor Int. J. Cancer 1991 48 258-264.
17. T. J. Dougherty C. J. Gomer B. W. Henderson G. Jori D. Kessel M. Korbelik J. Moan Q. Peng Photodynamic therapy J. Natl. Cancer Inst. 1998 90 889-905.
18. M. M. Zuk M. E. Kenney B. Horowitz Ben-E. Hur High-performance liquid chromatographic determination of the silicon phthalocyanine Pc 4 in human blood J. Chromatogr. B Biomed. Appl. 1995 673 320-324.
19. L. Kaestner Evaluation of human erythrocytes as model cells in photodynamic therapy Gen. Physiol. Biophys. 2003 22 455-465.
20. R. C. Straight, W. C. Stroop, J. D. Spikes and J. A. Dixon, in Photodynamic therapy of tumors and other diseases, ed. G. Jori and C. Perria, Libreria Progretto, Padua, 1985, pp. 353–358.
21. H. J. Alter R. P. Creagan P. A. Morel G. P. Wiesehahn B. P. Dorman L. Corash G. C. Smith H. Popper J. W. Eichberg Photochemical decontamination of blood components containing hepatitis B and non-A, non-B virus Lancet 1988 2 1446-1450.
22. J. L. Matthews J. T. Newman F. Sogandares-Bernal M. M. Judy H. Skiles J. E. Leveson A. J. Marengo-Rowe T. C. Chanh Photodynamic therapy of viral contaminants with potential for blood banking applications Transfusion 1988 28 81-83.
23. H. C. Neyndorff D. L. Bartel F. Tufaro J. G. Levy Development of a model to demonstrate photosensitizer-mediated viral inactivation in blood Transfusion 1990 30 485-490.
24. M. Wick, W. Pinggera and P. Lehmann, Iron Metabolism, Anemias. Diagnosis and Therapy, Springer, Wien–New York, 2000.
25. J. C. Kennedy R. H. Pottier Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy J. Photochem. Photobiol. B 1992 14 275-292.
26. C. Lentner and L. I. Woolf, in Wissenschaftliche Tabellen Geigy, Teilband Hämatologie und Humangenetik, ed. C. Lentner, Ciba-Geigy, Basel, 1979, pp. 248–287.
27. Ø. Bech, Q. Peng, K. Berg and J. Moan, in Photodynamic therapy and Biomedical Lasers, ed. P. Spinelli, M. Dal Fante and R. Marchesini, Elsevier Science Publishers, Amsterdam, 1992, pp. 521–525.
28. S. S. Bottomley M. Tanaka M. A. Everett Diminished erythroid ferrochelatase activity in protoporphyria J. Lab. Clin. Med. 1975 86 126-131.
29. A. F. de Goeij K. Christianse J. van Steveninck Decreased haem synthetase activity in blood cells of patients with erythropoietic protoporphyria Eur. J. Clin. Invest. 1975 5 397-400.
30. J. R. Bloomer Characterization of deficient heme synthase activity in protoporphyria with cultured skin fibroblasts J. Clin. Invest. 1980 65 321-328.
31. D. J. Todd Erythropoietic protoporphyria Br. J. Dermatol. 1994 131 751-766.
32. A. A. Lamola I. Asher Muller-U. Eberhard M. Poh-Fitzpatrick Fluorimetric study of the binding of protoporphyrin to haemopexin and albumin Biochem. J 1981 196 693-698.
33. S. Piomelli A. A. Lamola Poh-M. F. Fitzpatrick C. Seaman L. C. Harber Erythropoietic protoporphyria and lead intoxication: the molecular basis for difference in cutaneous photosensitivity. I. Different rates of disappearance of protoporphyrin from the erythrocytes, both in vivo and in vitro J. Clin. Invest. 1975 56 1519-1527.
34. S. Sandberg A. Brun Light-induced protoporphyrin release from erythrocytes in erythropoietic protoporphyria J. Clin. Invest. 1982 70 693-698.
35. A. Brun S. Sandberg Photodynamic release of protoporphyrin from intact erythrocytes in erythropoietic protoporphyria: the effect of small repetitive light doses Photochem. Photobiol. 1985 41 535-541.
36. A. Brun S. Sandberg Light-induced redistribution and photobleaching of protoporphyrin in erythrocytes from patients with erythropoietic protoporphyria: an explanation of the rapid fading of fluorocytes J. Photochem. Photobiol. B 1988 2 33-41.
37. A. Brun A. Western Z. Malik S. Sandberg Erythropoietic protoporphyria: photodynamic transfer of protoporphyrin from intact erythrocytes to other cells Photochem. Photobiol. 1990 51 573-577.
38. A. Brun, PhD Thesis, University of Bergen, Norway, 1993.
39. S. Thunell P. Harper A. Brun Porphyrins, porphyrin metabolism and porphyrias. IV. Pathophysiology of erythyropoietic protoporphyria–diagnosis, care and monitoring of the patient Scand. J. Clin. Lab. Invest. 2000 60 581-604.
40. M. B. Poh-Fitzpatrick The ‘priming phenomenon’ in the acute phototoxicity of erythropoietic protoporphyria J. Am. Acad. Dermatol. 1989 21 311.
41. R. M. Fusaro W. J. Runge Erythropoietic protoporphyria. IV. Protection from sunlight Br. Med. J. 1970 1 730-731.
42. M. F. Corbett A. Herxheimer I. A. Magnus C. A. Ramsay A. Kobza-Black The long term treatment with beta-carotene in erythropoietic protoporphyria: a controlled trial Br. J. Dermatol. 1977 97 655-662.
43. H. Baart de la Faille J. C. Bijlmer-Iest J. van Hattum J. Koningsberger L. H. Rademakers H. van Weelden Erythropoietic protoporphyria: clinical aspects with emphasis on the skin Curr. Probl. Dermatol. 1991 20 123-134.
44. M. Chopp M. R. Glasberg J. M. Riddle F. W. Hetzel K. M. Welch Photodynamic therapy of normal cerebral tissue in the cat: a noninvasive model for cerebrovascular thrombosis Photochem. Photobiol. 1987 46 103-108.
45. A. Orenstein J. S. Nelson L. H. Liaw R. Kaplan S. Kimel M. W. Berns Photochemotherapy of hypervascular dermal lesions: a possible alternative to photothermal therapy? Lasers Surg. Med. 1990 10 334-343.
46. S. H. Selman M. Kreimer-Birnbaum J. E. Klaunig P. J. Goldblatt R. W. Keck S. L. Britton Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light Cancer Res. 1984 44 1924-1927.
47. B. W. Henderson S. M. Waldow T. S. Mang W. R. Potter P. B. Malone T. J. Dougherty Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy Cancer Res. 1985 45 572-576.
48. W. M. Star H. P. Marijnissen A. E. van den Berg-Blok J. A. Versteeg K. A. Franken H. S. Reinhold Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers Cancer Res. 1986 46 2532-2540.
49. E. Ben-Hur A. Orenstein The endothelium and red blood cells as potential targets in PDT-induced vascular stasis Int. J. Radiat. Biol. 1991 60 293-301.
50. L. Kaestner, Passive elektrogene Transportprozesse durch die Membran von Humanerythrozyten und Erythrozyten von gesunden und Malaria-infizierten Hühnern, Logos Verlag, Berlin, 2001.
51. W. T. Geigy, in Teilband Somatometrie und Biochemie, Ciba-Geigy, Basel, 1982, pp. 157–158.
52. A. Cu G. G. Bellah D. A. Lightner Letter: On the fluorescence of bilirubin J. Am. Chem. Soc. 1975 97 2579-2580.
53. T. Christensen J. B. Reitan Phototoxic effects of bilirubin J. Photochem. Photobiol. B 1988 1 373-374.
54. T. Christensen E. B. Roll A. Jaworska G. Kinn Bilirubin- and light induced cell death in a murine lymphoma cell line J. Photochem. Photobiol. B 2000 58 170-174.
55. A. W. Girotti Photodynamic action of bilirubin on human erythrocyte membranes. Modification of polypeptide constituents Biochemistry 1975 14 3377-3383.
56. J. Moan, in Radiation - at home, outdoors and in the workplace, ed. J. Moan, Scandinavian Science Publisher, Oslo, 2001, pp. 69–85.
57. W. Schröter, in Kinderheilkunde, ed. G.-A. V. Harnack, Springer Verlag, Berlin, 1994, pp. 74–80.
58. D. Bratlid Bilirubin binding by human erythrocytes Scand. J. Clin. Lab. Invest. 1972 29 91-97.
59. D. Jährig B. Maass P. Meisel K. Jahrig U. Grimm H. Zollner Zur Frage photodynamischer Schäden an Erythrozyten unter Blaulichttherapie bei Icterus neonatorum Acta Biol. Med. Ger. 1981 40 811-819.
60. G. Alpert M. Shohat S. H. Reisner Y. L. Danon Osmotic fragility of erythrocytes in newborn infants treated by phototherapy Acta Paediatr. Scand. 1984 73 254-257.
61. J. O. Cukier A. C. Maglalang G. B. Odell Increased osmotic fragility of erythrocytes in chronically jaundiced rats after phototherapy Acta Paediatr. Scand. 1979 68 903-909.
62. E. B. Roll, T. Christensen and O. A. Gederaas, Effects of bilirubin and blue light on the osmotic fragility and the haematoporphyrin-induced delayed photohaemolysis of erythrocytes and spherocytes, Acta Paediatr., 2004, in press.
63. E. M. Bruzell, PhD Thesis, Norwegian University of Science and Technology, Trondheim, 2003.
64. H. J. Schatzmann, in The Red Cell Membrane. A Model for solute Transport, ed. B. U. Raess and G. Tunnicliff, Humana Press, Clifton, 1989, pp. 3–17.
65. M. O. Senge W. W. Kalisch Synthesis and Structural Characterization of Nonplanar Tetraphenylporphyrins and Their Metal Complexes with Graded Degrees of beta-Ethyl Substitution Inorg. Chem. 1997 36 6103-6116.
66. L. Kaestner, Tetraphenylporphyrine - Farbstoffe für die photodynamische Therapie, Logos Verlag, Berlin, 1997.
67. A. A. Krasnovskii N. N. Drozdoba I. M. Sapozhnikova Conditions of reversible and irreversible photo-oxidation of bacteriochlorophyll Dokl. Akad. Nauk SSSR 1967 177 1225-1228.
68. C. S. Foote Mechanisms of photosensitized oxidation. There are several different types of photosensitized oxidation which may be important in biological systems Science 1968 162 963-970.
69. A. M. Michelson P. Durosay Hemolysis of human erythrocytes by activated oxygen species Photochem. Photobiol. 1977 25 55-63.
70. 2 luminescence from the inside of a native membrane J. Photochem. Photobiol. B 1999 53 121-127.
71. C. Fabris G. Valduga G. Miotto L. Borsetto G. Jori S. Garbisa E. Reddi Photosensitization with zinc(II) phthalocyanine as a switch in the decision between apoptosis and necrosis Cancer Res. 2001 61 7495-7500.
72. A. M. Richter S. Yip H. Meadows A. K. Jain H. Neyndorff G. Moreno C. Salet J. G. Levy Photosensitizing potencies of the structural analogues of benzoporphyrin derivative in different biological test systems J. Clin. Laser Med. Surg. 1996 14 335-341.
73. L. Kaestner M. Cesson K. Kassab T. Christensen P. D. Edminson M. J. Cook I. Chambrier G. Jori Zinc octa-n-alkyl phthalocyanines in photodynamic therapy: photophysical properties, accumulation and apoptosis in cell cultures, studies in erythrocytes and topical application to Balb/c mice skin Photochem. Photobiol. Sci 2003 2 660-667.
74. L. Kaestner Red blood cell ghosts and intact red blood cells as complementary models in photodynamic cell research J. Bioelectrochem. 2004 62 123-126.
75. J. G. Moser, Photodynamic Tumor Therapy: 2nd and 3rd Generation Photosensitizers, Harwood Academic Publishers, Amsterdam, 1998.
76. D. J. Ball S. R. Wood D. I. Vernon J. Griffiths T. M. Dubbelman S. B. Brown The characterisation of three substituted zinc phthalocyanines of differing charge for use in photodynamic therapy. A comparative study of their aggregation and photosensitising ability in relation to mTHPC and polyhaematoporphyrin J. Photochem. Photobiol. B 1998 45 28-35.
77. T. Christensen and J. Moan, in Lasers in photomedicine and photobiology, ed. R. Pratesi and P. A. Sacci, Springer, Berlin, 1980, 87–91.
78. L. Kaestner C. Bollensdorff I. Bernhardt Non-selective voltage-activated cation channel in the human red blood cell membrane Biochim. Biophys. Acta 1999 1417 9-15.
79. C. Duranton S. M. Huber F. Lang Oxidation induces a Cl(-)dependent cation conductance in human red blood cells J. Physiol. 2002 539 847-855.
80. L. Kaestner P. Christophersen I. Bernhardt P. Bennekou The non-selective voltage-activated cation channel in the human red blood cell membrane: reconciliation between two conflicting reports and further characterisation Bioelectrochemistry 2000 52 117-125.
81. L. Kaestner I. Bernhardt Ion channels in the human red blood cell membrane: their further investigation and physiological relevance Bioelectrochemistry 2002 55 71-74.
82. B. Deuticke U. Henseleit C. W. Haest K. B. Heller T. M. Dubbelman Enhancement of transbilayer mobility of a membrane lipid probe accompanies formation of membrane leaks during photodynamic treatment of erythrocytes Biochim. Biophys. Acta 1989 982 53-61.
83. 2+ sensitivity of phospholipid scrambling in human red cell ghosts Cell Calcium 1999 25 313-320.
84. C. W. M. Haest, in Red Cell Membrane Transport in Health and Disease, ed. I. Bernhardt and J. C. Ellory, Springer Verlag, Berlin, 2003, pp. 1–26.
85. E. Ben-Hur G. Barshtein S. Chen S. Yedgar Photodynamic treatment of red blood cell concentrates for virus inactivation enhances red blood cell aggregation: protection with antioxidants Photochem. Photobiol. 1997 66 509-512.
86. A. A. Schothorst J. Van Steveninck L. N. Went D. Suurmond Protoporphyrin-induced photohemolysis in protoporphyria and in normal red blood cells Clin. Chim. Acta 1970 28 41-49.
87. J. P. Pooler The kinetics of colloid osmotic hemolysis. II. Photohemolysis Biochim. Biophys. Acta 1985 812 199-205.
88. J. P. Pooler The kinetics of colloid osmotic hemolysis. I. Nystatin-induced lysis Biochim. Biophys. Acta 1985 812 193-198.
89. L. I. Grossweiner, http://www.photobiology.com/reviews/5/index.htm, 1999.
90. K. S. Lang C. Duranton H. Poehlmann S. Myssina C. Bauer F. Lang T. Wieder S. M. Huber Cation channels trigger apoptotic death of erythrocytes Cell Death Differ. 2003 10 249-256.
91. F. Lang K. S. Lang T. Wieder S. Myssina C. Birka P. A. Lang S. Kaiser D. Kempe C. Duranton S. M. Huber Cation channels, cell volume and the death of an erythrocyte Pfluegers Arch. 2003 447 2 121-125.
92. J. D. Spikes, in Photoimmunology, ed. J. A. Parrish, M. L. Kripke and W. Morison, Plenum Press, New York, 1983, pp. 23–49.
93. W. J. Pape T. Maurer U. Pfannenbecker W. Steiling The red blood cell phototoxicity test (photohaemolysis and haemoglobin oxidation): EU/COLIPA validation programme on phototoxicity (phase II) Altern. Lab. Anim. 2001 29 145-162.
94. N. J. Traynor B. E. Johnson N. K. Gibbs Photohaemolysis assay for drug phototoxicity complicated by ‘bleaching of released haemoglobin’ Toxicol. Vitro 1996 10 619-624.
95. Y. Okamoto A. Ryu K. Ohkoshi In vitro alternatives and phototoxicity testing. I. Evaluation of in vitro phototoxicity assays Altern. Lab. Anim. 1999 27 639-644.
96. C. C. Winterbourn Free radical toxicology and antioxidant defence Clin. Exp. Pharmacol. Physiol. 1995 22 877-880.
97. E. Ben-Hur W. S. Chan Z. Yim M. M. Zuk V. Dayal N. Roth E. Heldman A. Lazo C. R. Valeri B. Horowitz Photochemical decontamination of red blood cell concentrates with the silicon phthalocyanine PC 4 and red light Dev. Biol. Stand. 2000 102 149-155.
98. A. C. Moor A. E. Wagenaars-van Gompel A. Brand M. A. Dubbelman J. VanSteveninck Primary targets for photoinactivation of vesicular stomatitis virus by AIPcS4 or Pc4 and red light Photochem. Photobiol. 1997 65 465-470.
99. X. J. Zhao S. Lustigman Y. S. Li M. E. Kenney E. Ben-Hur Structure-activity and mechanism studies on silicon phthalocyanines with Plasmodium falciparum in the dark and under red light Photochem. Photobiol. 1997 66 282-287.
100. H. Margolis-Nunno E. Ben-Hur P. Gottlieb R. Robinson J. Oetjen B. Horowitz Inactivation by phthalocyanine photosensitization of multiple forms of human immunodeficiency virus in red cell concentrates Transfusion 1996 36 743-750.
101. E. Ben-Hur, W. S. Chan, Z. Yim, M. M. Zuk, V. Dayal, N. Roth, E. Heldman, A. Lazo, C. R. Valeri and B. Horowitz, in Advances in Transfusion Safety, Dev. Biol., ed. F. Brown and G. Vyas, Karger, Basel, 1999, pp. 149–155.
102. E. Ben-Hur M. M. Zuk J. Oetjen W.-S. Chan L. Lenny B. Horowitz Photochemical Decontamination of Red Cell Concentrates with the Silicon Phthalocyanine Pc 4 and Red Light J. Biomed. Opt. 1999 4 292-297.
103. E. Ben-Hur M. M. Zuk S. Chin D. Banerjee M. E. Kenney B. Horowitz Biodistribution and virus inactivation efficacy of a silicon phthalocyanine in red blood cell concentrates as a function of delivery vehicle Photochem. Photobiol. 1995 62 575-579.
104. S. J. Wagner A. Skripchenko D. Thompson-Montgomery Quinacrine enhances vesicular stomatitis virus inactivation and diminishes hemolysis of dimethylmethylene blue-phototreated red cells Photochem. Photobiol. 2002 76 514-517.
105. G. A. Besselink F. A. Van Engelenburg H. G. Korsten D. E. Blokker J. W. Lagerberg A. Brand D. De Korte A. J. Verhoeven The band III ligand dipyridamole protects human RBCs during photodynamic treatment while extracellular virus inactivation is not affected Transfusion 2002 42 728-733.
106. I. Bernhardt A. C. Hall J. C. Ellory Transport Pathways for Monovalent Cations through Erythrocyte Membranes Stud. Biophys. 1988 126 5-21.
107. A. C. Moor A. van der Veen T. M. Dubbelman J. VanSteveninck A. Brand Photodynamic sterilization of red cells and its effect on contaminating white cells: viability and mechanism of cell death Transfusion 1999 39 599-607.
108. H. Bäumler I. Bernhardt U. Gimsa G. Gündel R. Ziegler H. Kiesewetter Transport of potassium ions in human red blood cells and lymphocyte survival in erythrocyte concentrates after gamma irradiation and during storage Beitr. Infusionsther. Transfusionsmed. 1997 34 63-70.
109. H. Mohr and A. Redecker-Klein, Photodecontamination in blood products by thionine and other phenothiazine dyes, in Programme and Book of Abstracts of the 10th Congress of the European Society for Photobiology, Vienna, 2003, p. 79.
110. O. M. Smith D. L. Traul L. McOlash F. Sieber Evaluation of merocyanine 540-sensitized photoirradiation as a method for purging malarially infected red cells from blood J. Infect. Dis. 1991 163 1312-1317.
111. A. Skripchenko D. Robinette S. J. Wagner Comparison of methylene blue and methylene violet for photoinactivation of intracellular and extracellular virus in red cell suspensions Photochem. Photobiol. 1997 65 451-455.
112. P. Grellier R. Santus E. Mouray V. Agmon J. C. Maziere D. Rigomier A. Dagan S. Gatt J. Schrevel Photosensitized inactivation of Plasmodium falciparum- and Babesia divergens-infected erythrocytes in whole blood by lipophilic pheophorbide derivatives Vox Sang 1997 72 211-220.
113. Y. Nakahashi S. Taketani M. Okuda K. Inoue R. Tokunaga Molecular cloning and sequence analysis of cDNA encoding human ferrochelatase Biochem. Biophys. Res. Commun. 1990 173 748-755.
114. R. P. Sarkany Porphyria. From Sir Walter Raleigh to molecular biology Adv. Exp. Med. Biol. 1999 455 235-241.
115. R. Pawliuk T. Bachelot R. J. Wise M. M. Mathews-Roth P. Leboulch Long-term cure of the photosensitivity of murine erythropoietic protoporphyria by preselective gene therapy Nat. Med. 1999 5 768-773.
116. A. Fontanellas M. Mendez F. Mazurier M. Cario-Andre S. Navarro C. Ged L. Taine F. Geronimi E. Richard F. Moreau-Gaudry R. Enriquez De Salamanca H. de Verneuil Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells Gene Ther. 2001 8 618-626.
117. E. Richard, E. Robert, M. Cario-Andre, C. Ged, F. Geronimi, S. L. Gerson, H. De Verneuil and F. Moreau-Gaudry, Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection, Gene Ther., 2004, in press.
118. L. Kaestner, W. Tabellion, P. Lipp and I. Bernhardt, Prostaglandin E2 activates channel-mediated calcium entry in human erythrocytes: An indication for a blood clot formation supporting process. Thromb. Haemostasis, 2004, 92, in press.
119. L. Kaestner W. Tabellion E. Weiss P. Lipp I. Bernhardt Signal molecules trigger calcium influxes into human erythrocytes Pfluegers Arch. 2004 447 S126.
120. D. R. Green J. C. Reed Mitochondria and apoptosis Science 1998 281 1309-1312.
121. T. J. McManus and W. F. Schmidt, in Membrane Transport Processes, ed. J. F. Hoffman, Raven Press, New York, 1978, pp. 79–106.
122. K. Konig S. Kimel M. W. Berns Photodynamic effects on human and chicken erythrocytes studied with microirradiation and confocal laser scanning microscopy Lasers Surg. Med. 1996 19 284-298.
123. A. Lazo J. Tassello V. Jayarama A. Ohagen V. Gibaja E. Kramer A. Marmorato D. Billia-Shaveet A. Purmal F. Brown J. Chapman Broad-spectrum virus reduction in red cell concentrates using INACTINE PEN110 chemistry Vox Sang 2002 83 313-323.
124. A. Ohagen V. Gibaja S. Aytay J. Horrigan D. Lunderville A. Lazo Inactivation of HIV in blood Transfusion 2002 42 1308-1317.
125. B. Zavizion M. Pereira M. de Melo Jorge D. Serebryanik T. N. Mather J. Chapman N. J. Miller B. Alford D. J. Bzik A. Purmal Inactivation of protozoan parasites in red blood cells using INACTINE PEN110 chemistry Transfusion 2004 44 731-738.
126. J. R. Chapman K. Moore B. E. Butterworth Pathogen inactivation of RBCs: PEN110 reproductive toxicology studies Transfusion 2003 43 1386-1393.
127. J. P. AuBuchon C. A. Pickard L. H. Herschel J. C. Roger J. E. Tracy A. Purmal J. Chapman S. Ackerman K. J. Beach Production of pathogen-inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical study Transfusion 2002 42 146-152.
128. P. Christophersen P. Bennekou Evidence for a voltage-gated, non-selective cation channel in the human red cell membrane Biochim. Biophys. Acta 1991 1065 103-106.